Figures & data
Figure 1. All patients treated with the Molecular Adsorbent Recirculating System at Oslo University Hospital, Rikshospitalet between March 2005 and January 2014.
![Figure 1. All patients treated with the Molecular Adsorbent Recirculating System at Oslo University Hospital, Rikshospitalet between March 2005 and January 2014.](/cms/asset/90b3aef3-fc6b-4f80-8a1d-98c821748da7/igas_a_1027262_f0001_ob.jpg)
Table I. Indications for molecular adsorbent recirculating system (MARS) treatment in 69 patients listed for liver transplantation in Norway since 2005.
Figure 2. Indications for treating patients listed for liver transplantation with the Molecular Adsorbent Recirculating System.
![Figure 2. Indications for treating patients listed for liver transplantation with the Molecular Adsorbent Recirculating System.](/cms/asset/fc9dd4ba-f6d0-46e1-b7f1-7c32d2d61a73/igas_a_1027262_f0002_ob.jpg)
Table II. Parameters measured before, during, and after start of treatment with the Molecular Adsorbent Recirculating System (MARS).
Table III. Univariate logistic regression analyses of ability to predict survival without (n = 4) or until (n = 56) liver transplantation in 69 patients listed for liver transplantation. Baseline values minus values after treatment with the Molecular Adsorbent Recirculating System (MARS) are covariates.
Table IV. Cox regression analyses of parameters ability to predict 30-days post liver transplantation survival in Molecular Adsorbent Recirculating System treated patients that were subsequently liver transplanted (n = 56). Baseline values minus values after MARS treatment are covariates. Only parameters that changed significantly during MARS treatment according to Table II were tested.